S

Shanghai Henlius Biotech Inc
HKEX:2696

Watchlist Manager
Shanghai Henlius Biotech Inc
HKEX:2696
Watchlist
Price: 68.25 HKD 1.26% Market Closed
Market Cap: 37.1B HKD

Intrinsic Value

The intrinsic value of one Shanghai Henlius Biotech Inc stock under the Base Case scenario is 29.39 HKD. Compared to the current market price of 68.25 HKD, Shanghai Henlius Biotech Inc is Overvalued by 57%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
29.39 HKD
Overvaluation 57%
Intrinsic Value
Price
S
Worst Case
Base Case
Best Case

Valuation History
Shanghai Henlius Biotech Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about Shanghai Henlius Biotech Inc?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Shanghai Henlius Biotech Inc valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Shanghai Henlius Biotech Inc.

Explain Valuation
Compare Shanghai Henlius Biotech Inc to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Shanghai Henlius Biotech Inc?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Shanghai Henlius Biotech Inc

Current Assets 3.2B
Cash & Short-Term Investments 889.2m
Receivables 1.3B
Other Current Assets 1B
Non-Current Assets 8.3B
PP&E 2.6B
Intangibles 5.7B
Other Non-Current Assets 27.5m
Current Liabilities 4.7B
Accounts Payable 774m
Other Current Liabilities 4B
Non-Current Liabilities 3.4B
Long-Term Debt 1.1B
Other Non-Current Liabilities 2.3B
Efficiency

Free Cash Flow Analysis
Shanghai Henlius Biotech Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Shanghai Henlius Biotech Inc

Revenue
5.8B CNY
Cost of Revenue
-1.4B CNY
Gross Profit
4.4B CNY
Operating Expenses
-3.5B CNY
Operating Income
931m CNY
Other Expenses
-106.7m CNY
Net Income
824.3m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Shanghai Henlius Biotech Inc's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
ROE is Increasing
Exceptional ROE
Exceptional Gross Margin
57/100
Profitability
Score

Shanghai Henlius Biotech Inc's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Shanghai Henlius Biotech Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Positive Net Debt
Average Altman Z-Score
50/100
Solvency
Score

Shanghai Henlius Biotech Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Shanghai Henlius Biotech Inc

Wall Street analysts forecast Shanghai Henlius Biotech Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shanghai Henlius Biotech Inc is 101.59 HKD with a low forecast of 95.95 HKD and a high forecast of 108.06 HKD.

Lowest
Price Target
95.95 HKD
41% Upside
Average
Price Target
101.59 HKD
49% Upside
Highest
Price Target
108.06 HKD
58% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Shanghai Henlius Biotech Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for Shanghai Henlius Biotech Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Shanghai Henlius Biotech Inc stock?

The intrinsic value of one Shanghai Henlius Biotech Inc stock under the Base Case scenario is 29.39 HKD.

Is Shanghai Henlius Biotech Inc stock undervalued or overvalued?

Compared to the current market price of 68.25 HKD, Shanghai Henlius Biotech Inc is Overvalued by 57%.

Back to Top